Related Experiment Video
Updated: Nov 6, 2025

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
Fungus fuels mucosal wounds in Crohn's disease
Kevin M Magnaye1, Susan V Lynch1
1Department of Medicine, University of California, San Francisco, CA, USA.
Abstract:
Intestinal microbiome perturbation characterizes Crohn's disease (CD), though specific contributors to pathophysiology remain elusive. In a recent issue of Science, Jain et al. show that Debaryomyces hansenii impairs intestinal healing in mice via effects on type I interferon signaling and chemokine CCL5 expression in macrophages and that it is also prevalent in the inflamed mucosa of CD patients.
Insights
The yeast Debaryomyces hansenii hinders gut healing in mice by affecting immune responses. This fungus is also found in inflamed tissues of Crohn's disease patients, suggesting a role in the condition.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Crohn's disease (CD) is linked to gut microbiome changes, but specific causative agents are unknown.
- Understanding factors contributing to CD pathophysiology is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of Debaryomyces hansenii in intestinal healing.
- To explore the mechanisms by which D. hansenii affects the host immune system in the context of gut inflammation.
Main Methods:
- Experiments were conducted in mouse models of intestinal healing.
- Analysis involved assessing the impact of D. hansenii on immune signaling pathways, specifically type I interferon and chemokine CCL5.
- Microbial and tissue samples from Crohn's disease patients were analyzed for the presence of D. hansenii.
Main Results:
- Debaryomyces hansenii was found to impair intestinal healing in mice.
- This impairment was associated with alterations in type I interferon signaling and CCL5 chemokine expression in macrophages.
- D. hansenii was identified as prevalent in the inflamed mucosa of patients with Crohn's disease.
Conclusions:
- Debaryomyces hansenii may contribute to the pathophysiology of Crohn's disease by hindering intestinal repair.
- The fungus's effects on macrophage immune signaling highlight a potential mechanism for its detrimental impact on gut health.
More Related Videos
08:52Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes
Published on: February 5, 2021
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
Related Concept Videos
Fungal Group Zygomycota
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Fungal Phylum Microsporidia